Chlamydia trachomatis is the most common bacterial agent of sexually transmitted infections and occurs in 1 million cases a year and is the largest reportable infection in the US. Researchers have designed a unique method for inducing immunity to the infection. The findings could accelerate progress toward developing a vaccine to guard against the infections of Chlamydia trachomatis which frequently lead to reproductive dysfunction and profound local inflammation that requires medical attention.